IP Update

Premium

Title: Pharmaceutical Composition for Obstructive Vascular Disease

Number: 20090047319

Filed: May 24, 2006 PCT Filed: May 24, 2006

Lead Inventor: Kenji Kadomatsu, Nagoya University

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.